1387P Final analysis of the phase Ib/II study of sabizabulin in men with metastatic castration-resistant prostate cancer who progressed on an androgen receptor targeting agent
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2022 33 Supplement 7:S1177-S1177 - Subject
- Language
- ISSN
- 0923-7534